Abstract
The malignant lymphomas represent multiple diseases with diverse morphologic and clinical expressions. Morphologic classification schemes have been shown to be useful in delineating natural history, prognosis and response to therapy (1). However, in some instances distinctive morphologic entities may be very closely related clinically and/or biologically, whereas other diseases that share morphologic similarities may be clinically and biologically quite distinct. The application of modern immunologic techniques and concepts has permitted the development of a conceptual framework which may be used to decipher the morphologic diversity of these neoplasms, and has shown the relationship of lymphoid and mononuclear phagocytic neoplasms to the normal immune system (2).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Rosenberg SA, Berard CW, Brown BW, Burke J, Dorfman RF, Glatstein E, Hoppe RT, Simon RT: National Cancer Institute sponsored study of classification of non-Hodgkin’s lymphomas: summary and description of a Working Formulation for clinical usage. Cancer(49).2112–2135, 1982.
Mann RB, Jaffe ES, Berard CW: Malignant lymphomas: a conceptual understanding of morphological diversity. Am J Pathol(94):105–192, 1979.
Jaffe ES, Braylan RC, Frank MM, Green I, Berard CW: Heterogeneity of immunologic markers and surface morphology in “childhood lymphoblastic lymphoma.” Blood(44):930, 1974.
Bollum FJ: Terminal deoxynucleotidyl transferase as a hematopoietic cell marker. A review. Blood(54):1203–1215, 1979.
Shibata A, Bennett JM, Castoldi GL, Catovsky D, Flandrin G, Jaffe ES, Katayama I, Nanba K, Schmalz I, F Yam LT: International Committee for Standardization in Hematology (ICSH). Recommended methods for cytochemical procedures in hematology. Clin Lab Haematol, in press.
Nanba J, Jaffe ES, Braylan RC, Soban EJ, Berard CW: Alkaline phosphatase positive malignant lymphomas. A subtype of B-cell lymphomas. Am J Clin Pathol(68):535–542, 1977.
Bowling MC: Histopathology Laboratory Procedures of the Pathologic Anatomy Branch of the National Cancer Institute. U.S. Govt. Printing Office, Washington, D.C., 1967.
Korsmeyer SJ, Hieter PA, Ravetch JV, Poplack DG, Waldmann TA, Leder P: Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B cells. Proc Natl Acad Sci USA(78): 7096–7100, 1981.
Cossman J, Neckers L, Arnold A, Korsmeyer S: Induction of differentiation in a case of common acute lymphoblastic leukemia. N Engl J Med(307):1251–1254, 1982.
Vogler LB, Crist W, Bockman DE, Pearl ER, Lawton AR, Cooper MD: Pre-B-cell leukemia. A new phenotype of childhood lymphoblastic leukemia. N Engl J Med(298):872–878, 1978.
Greaves MF, Janossy G, Roberts M, Rapson NT, Ellis RB, Chessels J, Lister TA, Catovsky D: Membrane phenotyping: diagnosis, monitoring and classification of acute “lymphoid” leukemias. In: Thierfeler S, Rodt H, Thiel, E (eds) Immunological Diagnoses of Leukemias and Lymphomas. Springer Verlag, New York, 1977, pp. 61–75.
Ritz J, Pesondo JM, Notis-McConarty J, Lazarus H, Schlossman SF: A monoclonal antibody to human acute lymphoblastic leukemia antigen. Nature(283): 583, 1980.
Korsmeyer SJ, Arnold A, Bakhshi A, Ravetch JV, Siebenlist U, Hieter PA, Sharrow SO, Le Bien TW, Kersey JH, Poplack DG, Leder P, Waldmann TA: Immunoglobulin gene rearrangements and cell surface antigen expression in acute lymphocytic leukemias of T-cell and B-cell precursor origins. J Clin Invest(71).301–313, 1983.
Cossman J, Chused T, Fisher R, Magrath I, Bollum FJ, Jaffe ES: Diversity of immunologic phenotypes of lymphoblastic lymphoma. Cancer Res(43):4486–4490, 1983.
Miller RA, Maloney DG, Levy R, Warnke R: Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. N Engl J Med(306): 517–522, 1982.
Arnold A, Cossman J, Bakhshi A, Jaffe ES, Waldmann TA, Korsmeyer SJ: Immunoglobulin gene rearrangements as unique clonal markers in human lymphoid neoplasms. N Engl J Med (309):1593–1599, 1983.
Cossman J, Neckers LM, Hsu SM, Longo D, Jaffe ES: Low grade lymphomas: Expression of developmentally regulated B-cell antigens. Am J Pathol(114):117–124, 1984.
Cossman J, Jaffe ES: Distribution of complement receptor subtypes in non-Hodgkin*s lymphomas of B-cell origin. Blood(58):20–26, 1981.
Royston I, Majda JA, Baird SM, Meserve BL, Griffiths JC: Human T-cell antigens defined by monoclonal antigens: The 65,000 dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin. J Immunol(125) :725–731, 1980.
Fu SM, Chiorazzi N, Kunkel HG, Halper JP, Harris SR: Induction of in vitro differentiation and immunoglobulin synthesis of human leukemic B lymphocytes. J Exp Med(148): 1570–1578, 1978.
Cossman J, Neckers LM, Braziel RM, Trepei JB, Korsmeyer SJ, Bakhshi A: In vitro enhancement of immunoglobulin gene expression in chronic lymphocytic leukemia. J Clin Invest(73):587–592, 1984.
Jaffe ES, Braylan RC, Nanba K, Frank MM, Berard CW: Functional markers: A new perspective on malignant lymphomas. Cancer Treat Rep(61):953–962, 1977.
Swerdlow SH, Habeshaw JA, Murray LJ, Dhaliwal HS, Lister TA, Stansfield AG: Centrocytic lymphoma: A distinct clinicopathologic and immunologic entity. Am J Pathol (113).181–197, 1983.
Jaffe ES, Shevach EM, Frank MM, Berard DW, Green I: Nodular lymphoma: Evidence for origin from follicular B lymphocytes. N Engl J Med(290):813, 1974.
Braziel RM, Neckers LM, Jaffe ES, Cossman J: Induction of immunoglobulin secretion in follicular non-Hodgkin’s lymphomas: Role of immunoregulatory T cells. Blood, in press.
Jaffe ES, Strauchen JA, Berard CW: Predictability of immunologic phenotype by morphologic criteria in diffuse aggressive non-Hodgkin’s lymphomas. Am J Clin Pathol(77): 46–49, 1982.
Mann RB, Jaffe ES, Braylan RC, Nanba K, Frank MM, Ziegler JL, Berard CW: Non-endemic Burkitt’s lymphoma. A B-cell tumor related to germinal centers. N Engl J Med(295):685–691, 1976.
Jaffe ES, Smith SA, Magrath IT, Freeman CB, Alabaster 0: Induction of complement receptors in human cell lines derived from undifferentiated lymphomas. Lab Invest (45):295–301, 1981.
Ritz J, Nadler LM, Bhan AK, Notis-McConarty J, Pesando JM, Schlossman SF: Expression of common acute lymphoblastic leukemia antigen (CALLA) by lymphomas of B- and T-cell lineage. Blood(58):648–652, 1981.
Braziel RM, Keneklis T, Donion JA, Hsu SM, Cossman J, Bollum FJ, Jaffe ES: Terminal deoxynucleotidyl transferase in non-Hodgkin* s lymphoma. Am J Clin Pathol(80) :655–659, 1983.
Croce CM, Tsujimoto Y, Erikson J, Nowell PC: Chromosomal translocation and B-cell neoplasia. Lab Invest(51):258–267, 1984.
Braylan RC, Jaffe ES, Triche JJ, Nanba K, Fowkles BJ, Metzger H, Frank MM, Do Ian MS, Yee CL, Green I, Berard CW: Structural and functional properties of the “hairy” cells of leukemic reticuloendotheliosis. Cancer(41): 210–227, 1978.
Cohen HJ, George ER, Kremer WB: Hairy cell leukemia: Cellular characteristics including surface immunoglobulin dynamics and biosynthesis. Blood(53): 764, 1979.
Korsmeyer S, Greene W, Cossman J, Hsu SM, Neckers L, Marshall S, Jensen J, Bakhshi A, Leonard W, Jaffe ES, Waldmann T: Rearrangement and expression of immunoglobulin genes and expression of TAC antigen in hairy cell leukemia. Proc Natl Acad Sci USA(80):4522–4526, 1983.
Anderson KC, Bates MP, Slaughenhoupt BL, Pinkus GS, Schlossman SF, Nadler LM: Expression of human B-cell-associated antigens on leukemias and lymphomas: A model of human B-cell differentiation. Blood(63):1425–1433, 1984.
Bernard A, Boumsell L, Reinherz EL, Nadler LM, Ritz J, Coppin H, Richard Y, Valensi F, Dausset J, Flandrin G, Lemerle J, Schlossman SF: Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: Evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma. Blood(57): 1105–1110, 1981.
Brouet JC, Flandrin G, Sasportes M, Preud’homme JL, Seligmann M: Chronic lymphocytic leukemia of T-cell origin. Lancet(ii)890–893, 1975.
Pandolfi F, Strong DM, Slease RB, Smith ML, Ortaldo JR, Herberman RB: Characterization of a suppressor T-cell chronic lymphocytic leukemia with ADCC but not NK activity. Blood(56).653–660, 1980.
Hooks JJ, Haynes BF, Detrick-Hooks D, Diehl LF, Gerrard TL, Fauci AS: Gamma (immune) interferon production by leukocytes from a patient with Tγ -cell proliferative disease. Blood(59):198–201, 1982.
Aisenberg AC, Wilkes BM, Harris NL, Ault KA, Carey RW: Chronic T-cell lymphocytosis with neutropenia: Report of a case studied with monoclonal antibodies. Blood(58): 818–822, 1981.
Broder S, Bunn PA Jr: Cutaneous T-cell lymphomas. Semin Oncol(7):310–331, 1980.
Broder S, Waldmann TA: Helper activity by lymphocytes derived from patients with the Sezary syndrome. J Clin Invest(58).1297–1306, 1976.
Jaffe ES: Pathologic and clinical spectrum of post-thymic T-cell malignancies. Special article. Cancer Investigation 2(5), 1984.
Cossman J, Jaffe ES, Fisher RI: Immunologic phenotypes of diffuse aggressive non-Hodgkin’s lymphomas: Correlation with clinical features. Cancer(54):1310–1317, 1984.
Jaffe ES, Blattner WA, Blayney DW, Bunn PA Jr, Cossman J, Robert-Guroff M, Gallo RC: The pathologic spectrum of HTLV-associated leukemia lymphoma in the United States. Am J Surg Pathol(8): 263–275, 1984.
Blayney D, Jaffe E, Blattner W, Cossman J, Robert-Guroff M, Longo D, Bunn P, Gallo R: The human T-cell leukemia/ lymphoma virus (HTLV) associated with American adult T-cell leukemia/lymphoma (ATL). Blood(62):401–405, 1983.
Jaffe ES, Costa J, Fauci AS, Cossman J, Tsokos M: Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis. Am J Med(75): 741–749, 1983.
Simrell CR, Crabtree GR, Cossman J, Fauci AS, Jaffe ES: Stimulation of phagocytosis by a T-cell-lymphoma-derived lymphokine. JEn: Vitetta E (ed) B- and T-Cell Tumors. UCLA Symposia in Molecular and Cellular Biology. Vol 24. Academic Press, New York, 1982, pp. 247–252.
Jaffe ES, Shevach EM, Sussman EH, Frank MM, Green I, Berard CW: Membrane receptor sites for the identification of lymphoreticular cells in benign and malignant conditions. Br J Cancer(31(Suppl II))107–120, 1975.
Risdall RJ, McKenna RW, Nesbit ME, Krivit W, Balfour HH, Simmons RL, Brunning RD: Virus-associated hemophagocytic syndrome, a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer(44):993–1002, 1979.
Van der Valk P, Meijer CJLM, Willemze R, Oosterom AT, Spaander PJ, Te Velde J: Histiocytic sarcoma (true histiocytic lymphoma) a clinico-pathological study of 20 cases. Histopathology(8):105–123, 1984.
Breard J, Reinherz EL, Kung PC, Goldstein G, Schlossman SF: A monoclonal antibody reactive with human blood monocytes. J Immunol(124): 1943–1948, 1980.
Hsu SM, Jaffe ES: Leu Ml and peanut agglutinin stain the neoplastic cells of Hodgkin’s disease. Am J Clin Pathol (82):29–32 1984.
Isaacson P, Wright DH, Jones DB: Malignant lymphoma of true histiocytic (monocyte/macrophage) origin. Cancer (51):80–91, 1983.
Young RC, Corder MA, Haynes HA, DeVita VT: Delayed hypersensitivity in Hodgkin’s disease. A study of 103 cases. Am J Med(52):63–72, 1973.
Levy R, Kaplan HS: Impaired lymphocyte function in untreated Hodgkin’s disease. N Engl J Med(290): 181–186, 1974.
Fuks Z, Strober S, Kaplan HS: Interaction between serum factors and T lymphocytes in Hodgkin* s disease. N Engl J Med(295):1273–1278, 1976.
Garvin AJ, Spicer SS, Parmley RT, Munster AM: Immunohisto-chemical demonstration of IgG in Reed-Sternberg and other cells in Hodgkin’s disease. J Exp Med(139):1077–1083, 1974.
Cossman J, Deegan MJ, Schnitzer B: Complement receptor B lymphocytes in nodular sclerosing Hodgkin’s disease. Cancer(39):2166–2174, 1977.
Kadin ME, Stites DP, Levy R, Warnke R: Exogenous immunoglobulin and the macrophage origin of Reed-Sternberg cells in Hodgkin’s disease. N Engl J Med(299):1208, 1978.
Kadin ME: Possible origin of the Reed-Sternberg cell from an interdigitating reticulum cell. Cancer Treat Rep(66): 601–608, 1982.
Longmire RL, McMillan R, Yelenosky R, Armstrong S, Lang JE, Craddock CG: In vitro splenic IgG synthesis in Hodgkin’s disease. N Engl J Med(289): 763–767, 1973.
DeVita VT: Lymphocyte reactivity in Hodgkin’s disease: A lymphocyte civil war. N Engl J Med(289):801–802, 1973.
Diehl V, Kirschner HH, Burrighter H, Stein H, Fonatsch C, Gerdes J, Schaadt M, Heit W, Uchanska-Ziegler B, Ziegler A, Heintz F, Sueno K: Characteristics of Hodgkin’s-disease-derived cell lines. Cancer Treat Rep(66):615–632, 1982.
Stein H, Gerdes J, Schwab U, Lemke H, Mason DY, Ziegler A, Schienle W, Diehl U: Identification of Hodgkin and Sternberg-Reed Sternberg cells as a unique cell type derived from a newly detected small cell population. Int J Cancer(30):445–459, 1982.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Jaffe, E.S., Cossman, J. (1985). Immunodiagnosis of Lymphoid and Mononuclear Phagocytic Neoplasms. In: Russo, J. (eds) Immunocytochemistry in Tumor Diagnosis. Developments in Oncology, vol 34. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2615-1_7
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2615-1_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9636-2
Online ISBN: 978-1-4613-2615-1
eBook Packages: Springer Book Archive